Amicus Therapeutics announced the appointment of Michael Diem, MD, MBA '05, as Senior Vice President of Business and Corporate Development. Diem will be responsible for leading all business and corporate development activities.
"I am pleased to welcome Dr. Mike Diem to our senior leadership team at Amicus," said John F. Crowley, Chairman and Chief Executive Officer of Amicus. "Mike has an outstanding track record in global business development and corporate strategy within the biotechnology and pharmaceutical industries. Mike will be a key leader for Amicus as we evaluate strategies to enhance our portfolio of leading edge rare disease medicines and technologies. He will be extremely valuable to Amicus as we continue to build a top global biotechnology company focused on devastating rare diseases."
Interested in learning more about Weatherhead programs? Request more information or apply now, or register for one of over 70 open enrollment courses through Executive Education.
Weatherhead School of Management at Case Western Reserve University cultivates creativity, innovation, and purpose-driven leadership to design a better world.